.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research highlights that the Cardiometabolic Index liver fibrosis association is a vital area for early clinical screening. This study utilized data from 3,170 participants from the National Health and Nutrition Examination Survey (NHANES) to evaluate how obesity-related markers influence liver stiffness. Furthermore, researchers investigated the mediating role of oxidative stress in this pathological process.
The Cardiometabolic Index (CMI) serves as a potent indicator of metabolic dysfunction. It combines lipid profiles and abdominal obesity measurements into a single metric. Consequently, scientists discovered that participants in the highest CMI quartiles faced more than double the risk of developing liver fibrosis compared to those in the lowest quartile. Specifically, the relationship appears linear, meaning that as metabolic health markers decline, liver health deteriorates proportionally. Moreover, these findings remained significant even after adjusting for confounding factors like age, gender, and lifestyle choices.
However, the study also explored the biological drivers behind this association. Results indicated that oxidative stress factors significantly mediate the link between metabolic health and hepatic damage. Specifically, serum albumin and γ-glutamyl transferase (GGT) accounted for 10.9% and 15.6% of the association, respectively. Therefore, high CMI values may trigger oxidative damage, which then accelerates the progression of liver fibrosis. Additionally, uric acid showed a minor mediating effect. Hence, monitoring these specific biomarkers provides clinicians with a clearer picture of a patient's risk profile. Collectively, these insights suggest that managing metabolic health could prevent serious liver complications through the reduction of oxidative stress.
The CMI is a clinical calculation that multiplies the triglyceride-to-HDL cholesterol ratio by the waist-to-height ratio. It helps identify patients at high risk for metabolic disorders and cardiovascular disease.
Oxidative stress involves an imbalance between free radicals and antioxidants in the body. In the liver, this process causes inflammation and cell damage, eventually leading to the buildup of scar tissue known as fibrosis.
Yes. Since GGT acts as a mediator of oxidative stress, elevated levels often correlate with metabolic dysfunction and can signal the early stages of liver disease.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional consultation. Refer to the latest local and national guidelines for clinical practice.
References
1. Yan C et al. Association Between Cardiometabolic Index and Liver Fibrosis: Mediation Analysis of Oxidative Stress Factors. Anatol J Cardiol. 2026 Apr 15. doi: 10.14744/AnatolJCardiol.2026.5715. PMID: 41983336.
2. National Health and Nutrition Examination Survey (NHANES). 2017-2020 Data Documentation and Analysis.
3. Lu H et al. The role of oxidative stress in metabolic-associated steatotic liver disease progression.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study found that a higher Cardiometabolic Index (CMI) significantly increases liver fibrosis risk, with oxidative stress markers acting as key mediators....
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
